VKTX$26.821.69%-0.46
After Hours: 26.92+0.10 +0.37%
Viking Therapeutics Inc (VKTX)
Date: 2026-11-02 16:00O: 27.25H: 27.90L: 26.54C: 26.82Vol: 3.991M
Viking Therapeutics Inc stock is traded at $26.82, with a volume of 3,991,062. It is down -1.69% in the last 24 hours and down -10.42% over the past month. Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Previous Close:
$27.28
Open:
$27.25
24h Volume:
3,991,062
Relative Volume:
0.92
Market Cap:
$3.42B
Revenue:
-
Net Income/Loss:
-$472.34M
P/E Ratio:
-
EPS:
-$4.15
Net Cash Flow:
-$340.33M
1W Performance:
+10.78%
1M Performance:
-10.42%
6M Performance:
-10.60%
1Y Performance:
-29.57%
1-Day Range:
$26.54$27.90
1-Week Range:
$23.82$27.90
52-Week Range:
$23.82$43.15
Viking Therapeutics Inc Stock (VKTX) Company Profile
Name
Viking Therapeutics IncSector
HealthcareIndustry
BiotechnologyPhone
858-704-4660Address
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA, USACompare VKTX vs VRTX, REGN, MRNA, ARGX, ONC
| Stocks | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|
VKTX Viking Therapeutics Inc | $3.42B | $0 | -$627.20M | -$340.33M | -$4.15 |
 VRTX Vertex Pharmaceuticals Inc | $140.94B | $12.59B | $4.41B | $3.71B | $16.87 |
 REGN Regeneron Pharmaceuticals Inc | $99.46B | $16.90B | $4.82B | $3.79B | $41.04 |
 MRNA Moderna Inc | $88.17B | $2.23B | -$3.15B | -$1.60B | -$8.15 |
 ARGX Argen X Se Adr | $55.03B | $4.16B | $1.29B | $734.26M | $19.58 |
 ONC Beone Medicines Ltd Adr | $40.86B | $6.13B | $655.71M | $1.10B | $4.48 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
Viking Therapeutics Inc Stock (VKTX) Financials Data
Viking Therapeutics Inc Stock (VKTX) Insider Trading
- Lian BrianJul 29 '26President & CEO
- Transaction
- Sale
- Cost
- $33.32
- #Shares
- 148,517
- Value ($)
- 4,947,888
- #Shares Total
- 2,572,441
- MARIANNA MANCINIJul 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $33.47
- #Shares
- 18,217
- Value ($)
- 609,636
- #Shares Total
- 0
- GREG ZANTEJul 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $33.47
- #Shares
- 21,217
- Value ($)
- 710,141
- #Shares Total
- 0
- BRIAN LIANJul 29 '26Officer
- Transaction
- Proposed Sale
- Cost
- $33.32
- #Shares
- 148,517
- Value ($)
- 4,947,888
- #Shares Total
- 0
- Mancini MariannaJul 29 '26Chief Operating Officer
- Transaction
- Sale
- Cost
- $33.47
- #Shares
- 18,217
- Value ($)
- 609,636
- #Shares Total
- 422,760
- ZANTE GREGJul 29 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $33.47
- #Shares
- 21,217
- Value ($)
- 710,141
- #Shares Total
- 212,204
- Aubuchon Neil WilliamMar 10 '26Chief Commercial Officer
- Transaction
- Buy
- Cost
- $33.50
- #Shares
- 4,475
- Value ($)
- 149,912
- #Shares Total
- 4,475
- GREG ZANTEJan 05 '26Officer
- Transaction
- Proposed Sale
- Cost
- $32.98
- #Shares
- 57,661
- Value ($)
- 1,901,470
- #Shares Total
- 0
- BRIAN LIANJan 05 '26Officer
- Transaction
- Proposed Sale
- Cost
- $32.96
- #Shares
- 233,409
- Value ($)
- 7,692,134
- #Shares Total
- 0
- MARIANNA MANCINIJan 05 '26Officer
- Transaction
- Proposed Sale
- Cost
- $32.98
- #Shares
- 57,661
- Value ($)
- 1,901,406
- #Shares Total
- 0
